226 related articles for article (PubMed ID: 25938351)
41. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
42. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
Ladstein RG; Bachmann IM; Straume O; Akslen LA
BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of phospho-histone H3 in prostate carcinoma.
Nowak M; Svensson MA; Carlsson J; Vogel W; Kebschull M; Wernert N; Kristiansen G; Andrén O; Braun M; Perner S
World J Urol; 2014 Jun; 32(3):703-7. PubMed ID: 23887713
[TBL] [Abstract][Full Text] [Related]
44. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Laurinavicius A; Laurinaviciene A; Ostapenko V; Dasevicius D; Jarmalaite S; Lazutka J
Diagn Pathol; 2012 Mar; 7():27. PubMed ID: 22424533
[TBL] [Abstract][Full Text] [Related]
46. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
Gunia S; Kakies C; Erbersdobler A; Koch S; May M
J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964
[TBL] [Abstract][Full Text] [Related]
47. Counting mitoses by image processing in Feulgen stained breast cancer sections: the influence of resolution.
Beliën JA; Baak JP; van Diest PJ; van Ginkel AH
Cytometry; 1997 Jun; 28(2):135-40. PubMed ID: 9181303
[TBL] [Abstract][Full Text] [Related]
48. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
[TBL] [Abstract][Full Text] [Related]
49. Anti-Phosphohistone H3-Positive Mitoses Are Linked to Pathological Response in Neoadjuvantly Treated Breast Cancer.
Timme S; Sillem M; Bronsert P; Bogatyreva L; Hauschke D; Zur Hausen A; Werner M; Stickeler E
Breast Care (Basel); 2017 Sep; 12(4):244-250. PubMed ID: 29070988
[TBL] [Abstract][Full Text] [Related]
50. Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
Stålhammar G; Robertson S; Wedlund L; Lippert M; Rantalainen M; Bergh J; Hartman J
Histopathology; 2018 May; 72(6):974-989. PubMed ID: 29220095
[TBL] [Abstract][Full Text] [Related]
51. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
[TBL] [Abstract][Full Text] [Related]
52. Paradoxical results obtained with Ki67-labeling and PHH3-mitosis index in glial tumors: a literature analysis.
Elmaci İ; Altinoz MA; Bolukbasi FH; Yapicier O; Sav A
Clin Neuropathol; 2017; 36(6):272-282. PubMed ID: 28853695
[TBL] [Abstract][Full Text] [Related]
53. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count.
Khieu ML; Broadwater DR; Aden JK; Coviello JM; Lynch DT; Hall JM
Am J Clin Pathol; 2019 May; 151(6):542-550. PubMed ID: 30788495
[TBL] [Abstract][Full Text] [Related]
54. Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.
Zhu P; Zhang CB; Yang P; Chen J; Liu YQ; Hu HM; Huang H; Bao ZS; Zhang W; Kong WJ; Jiang T
Oncotarget; 2016 Jul; 7(29):45005-45014. PubMed ID: 27323851
[TBL] [Abstract][Full Text] [Related]
55. The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.
Kim JY; Jeong HS; Chung T; Kim M; Lee JH; Jung WH; Koo JS
Oncotarget; 2017 Sep; 8(39):65064-65076. PubMed ID: 29029412
[TBL] [Abstract][Full Text] [Related]
56. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
[TBL] [Abstract][Full Text] [Related]
57. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
[TBL] [Abstract][Full Text] [Related]
58. Association Between Phosphorylated Histone H3 and Oncotype DX Recurrence Scores in Breast Cancer.
Lee LH; Swanson PE; Tang PA; Bigras G; Yang H
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):25-31. PubMed ID: 26371428
[TBL] [Abstract][Full Text] [Related]
59. The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
Saffar H; Okhovat H; Arbabsoleymani S; Tavangar SM; Khoshnevisan A; Hajinasrollah G; Hamidi Afra Z; Saffar H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2049-2052. PubMed ID: 34319026
[TBL] [Abstract][Full Text] [Related]
60. Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category.
Del Sordo R; Bellezza G; Ferri I; Pireddu A; Colella R; Sidoni A
Histol Histopathol; 2018 Jan; 33(1):81-88. PubMed ID: 28332699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
